The stock of Core Laboratories Inc (CLB) has gone down by -10.44% for the week, with a 6.03% rise in the past month and a -7.46% drop in the past quarter. The volatility ratio for the week is 5.34%, and the volatility levels for the past 30 days are 4.38% for CLB. The simple moving average for the past 20 days is -5.57% for CLB’s stock, with a -7.06% simple moving average for the past 200 days.
Is It Worth Investing in Core Laboratories Inc (NYSE: CLB) Right Now?
The price-to-earnings ratio for Core Laboratories Inc (NYSE: CLB) is above average at 27.21x, Company’s 36-month beta value is 2.39.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 1 as “sell.”
The public float for CLB is 46.48M, and currently, short sellers hold a 13.33% ratio of that floaft. The average trading volume of CLB on January 31, 2025 was 288.02K shares.
CLB) stock’s latest price update
The stock price of Core Laboratories Inc (NYSE: CLB) has plunged by -4.26 when compared to previous closing price of 18.54, but the company has seen a -10.44% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-01-30 that Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno – Chairman and Chief Executive Officer Gwen Gresham – Senior Vice President and Head, Investor Relations Chris Hill – Chief Financial Officer Conference Call Participants Stephen Gengaro – Stifel Josh Jayne – Daniel Energy Partners David Smith – Pickering Energy Partners Operator Good day, and welcome to the Core Laboratories’ Fourth Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Analysts’ Opinion of CLB
Many brokerage firms have already submitted their reports for CLB stocks, with Citigroup repeating the rating for CLB by listing it as a “Sell.” The predicted price for CLB in the upcoming period, according to Citigroup is $21 based on the research report published on June 30, 2023 of the previous year 2023.
BofA Securities, on the other hand, stated in their research note that they expect to see CLB reach a price target of $21.50. The rating they have provided for CLB stocks is “Underperform” according to the report published on April 18th, 2023.
CLB Trading at -7.04% from the 50-Day Moving Average
After a stumble in the market that brought CLB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.37% of loss for the given period.
Volatility was left at 4.38%, however, over the last 30 days, the volatility rate increased by 5.34%, as shares surge +3.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.03% lower at present.
During the last 5 trading sessions, CLB fell by -10.44%, which changed the moving average for the period of 200-days by +1.43% in comparison to the 20-day moving average, which settled at $18.80. In addition, Core Laboratories Inc saw 2.54% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CLB
Current profitability levels for the company are sitting at:
- 0.11 for the present operating margin
- 0.38 for the gross margin
The net margin for Core Laboratories Inc stands at 0.06. The total capital return value is set at 0.12. Equity return is now at value 13.01, with 5.34 for asset returns.
Based on Core Laboratories Inc (CLB), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at 1.27. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is 4.61.
Currently, EBITDA for the company is 72.76 million with net debt to EBITDA at 0.34. When we switch over and look at the enterprise to sales, we see a ratio of 1.64. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.89. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.32.
Conclusion
In a nutshell, Core Laboratories Inc (CLB) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
